Hot-Topics Mergers-and-Acquisitions 
Pharmaceutical Technology
DECEMBER 27, 2022
Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced. Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced.
pharmaphorum
APRIL 29, 2021
Kaia Health has just announced a $75 million funding round for its technology, aimed at improving musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD) care. Founder and CEO Konstantin Mehl spoke to pharmaphorum’s news editor Richard Staines about why these treatments will be in demand as the world emerges from the pandemic.
pharmaphorum
APRIL 19, 2021
But Dix has also been leading the UK’s Vaccine Taskforce, after taking over the hot seat in December following the departure of Kate Bingham. Before that he headed research and was a board member at PowderJect Pharmaceuticals until an acquisition by Chiron Vaccines in 2003.
Expert insights. Personalized for you.
122 
Let's personalize your content